RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. CMT Research Foundation
C

CMT Research Foundation portfolio

CMT Research Foundation has 1 portfolio company on record at Recent Funding.

Type: Investor.
Portfolio on Recent Funding: 1.
Deals, last 12 months: 0.
Capital in their rounds: $103.17M.
Latest deal: Augustine Therapeutics · Mar 24, 2025.
About this page

Its most recent investment on record is Augustine Therapeutics's $85M Series A round in March 2025, alongside Asabys Partners, Newton Biocapital, Novo Holdings and 6 others. That company is in Health and bio. It has co-invested with PMV, V-Bio Ventures and Asabys Partners, most often PMV (2 rounds).

What CMT Research Foundation invests in

How CMT Research Foundation invests

StageDealsCapital in rounds
Series A 2 100%$103.17M
YearDealsCapital in rounds
2024 1 50%$18.17M
2025 1 50%$85M

CMT Research Foundation portfolio companies

CompanyRound with CMT Research FoundationTotal raisedLatest raise
AAugustine Therapeutics
Health and bio
 Series A · $85M$103.17MMar 24, 2025
Series A

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Share is of the 2 rounds on Recent Funding that name CMT Research Foundation. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists CMT Research Foundation, which is a subset of its real portfolio. API: /api/v1/investors/cmt-research-foundation (get a free API key). More: the most active VC firms and new venture capital funds.